IPR filing up 64% in February compared with previous month

March 09, 2015

February was a busy month for PTAB petition filing, and also included a rare reversal of a split decision from the Board as well as the first set of final written decisions on biopharmaceutical IPRs

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

News United States Patents North America Jurisdictions

Important dates for the Women in Business Law Awards for 2024 revealed

John Harrison, December 05, 2023

Each week Managing IP speaks to a different IP lawyer about their life and career

Max Walters, December 05, 2023

Negrão is the executive director of the EUIPO in Alicante

December 04, 2023

Mrs Justice Joanna Smith identified inconsistencies between evidence given by Stability AI’s CEO and comments he made in the media

Rory O’Neill, December 04, 2023

The Chongqing First Intermediate People’s Court ruled Oppo must pay for the entire unlicensed period it used the Finnish company’s technology

Sukanya Sarkar, December 04, 2023

Firms explain how monitoring, referrals and relationships with foreign firms helped them get more work at the TTAB

Rani Mehta, December 01, 2023

Luke Toft explains why he moved back to Fox Rothschild after working in-house at Sleep Number for five months

Rani Mehta, December 01, 2023

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Rory O’Neill, December 01, 2023

In a seminal ruling, the Beijing Internet Court said images generated by Stable Diffusion counted as original works

Sukanya Sarkar, November 30, 2023

Boston-based John Lanza is hoping to work more with life sciences colleagues on the ‘exciting’ application of AI to drug discovery

Rani Mehta, November 30, 2023